SAVR vs TAVR - Bicuspid, endocarditis and anticoagulation

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d9/dc/0d/d9dc0d2a-e54a-6521-dbe2-c6ec8e5dfc44/mza_11703460016194122313.jpg/600x600bb.jpg

The Cardiac Exchange

Medtronic

45 episodes

1 month ago

A podcast series from Medtronic that goes straight to your ears to your heart. Join cardiac surgery professionals as they discuss recent developments in patient care, advancements in therapy technology and share personal experiences.

Medicine

Health & Fitness

RSS

All content for The Cardiac Exchange is the property of Medtronic and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

SAVR vs TAVR - Bicuspid, endocarditis and anticoagulation

The Cardiac Exchange

15 minutes

2 years ago

SAVR vs TAVR - Bicuspid, endocarditis and anticoagulation

Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.